ProCure Proton Therapy Center Pushes Breast Cancer Screenings Amid New Survival Data
Event summary
- ProCure Proton Therapy Center is urging women in Central New Jersey and the greater New York metro area to schedule breast cancer screenings ahead of Mother's Day 2026.
- New research in Oncology Nurse Advisor shows that even stage IV breast cancer detected through routine screening has better survival outcomes.
- ProCure offers proton therapy, an advanced radiation treatment that minimizes exposure to healthy tissue, particularly beneficial for breast cancer patients.
- The center has treated over 7,800 patients since opening in March 2012, including 750+ pediatric cases.
The big picture
ProCure's campaign aligns with a broader industry shift toward preventive care and precision medicine, particularly in oncology. The center's focus on proton therapy highlights the growing demand for treatments that reduce collateral damage to healthy tissue, a key differentiator in competitive cancer care markets. With over 7,800 patients treated since 2012, ProCure is leveraging its established expertise to drive awareness and adoption of advanced screening and treatment options.
What we're watching
- Screening Adoption
- Whether the new data on advanced-stage detection will accelerate screening rates among hesitant populations.
- Treatment Differentiation
- How ProCure's emphasis on proton therapy could position it as a leader in targeted cancer treatment.
- Regional Expansion
- The pace at which ProCure can extend its reach beyond Central New Jersey and the greater New York metro area.
Related topics